Skip to main content
. 2011 Dec 30;2(12):1254–1264. doi: 10.18632/oncotarget.406

Table 1. Functional classification of the 97 genes associated with response to GSK461364A.

The DAVID Gene Functional Classification Tool was used to analyze the 97 genes targeted by the 201 shRNAs associated with response to GSK461364A. The resultant groupings and 50 genes are listed here, together with the average shRNA relative abundance (drug treatment vs. mock treatment) on a log2 scale.

Grouped Genes Description shRNA effect
Cell surface receptor linked signal transduction
CSF1R colony stimulating factor 1 receptor −0.30
DDR1 discoidin domain receptor tyrosine kinase 1 −0.41
EGFR epidermal growth factor receptor −0.50
GUCY2D guanylate cyclase 2D, membrane −0.46
IGF1R insulin-like growth factor 1 receptor −0.28
KIT proto-oncogene tyrosine-protein kinase Kit −0.45
TGFBR1 transforming growth factor, beta receptor 1 −0.54
TIE1 tyrosine kinase with immunoglobulin-and EGF-like domains −0.52
Protein kinase
BMX BMX non-receptor tyrosine kinase −0.86
CAMKK1 calmodulin-dependent protein kinase kinase −0.86
CDC7 cell division cycle 7 homolog (S. cerevisiae) −0.39
CDK7 cyclin-dependent kinase 7 −0.34
CSF1R colony stimulating factor 1 receptor −0.29
CSNK1G1 casein kinase 1, gamma 1 −0.55
CSNK2A2 casein kinase 2, alpha prime polypeptide −0.44
DDR1 discoidin domain receptor tyrosine kinase 1 −0.41
DYRK4 dual-specificity tyrosine-(Y)-phosphoryl. regulated kinase 4 −0.47
EIF2AK2 eukaryotic translation initiation factor 2-alpha kinase 2 −0.25
ICK intestinal cell (MAK-like) kinase −0.42
LATS2 LATS, large tumor suppressor, homolog 2 (Drosophila) −0.54
MAP2K6 mitogen-activated protein kinase kinase 6 0.61
MAP2K7 mitogen-activated protein kinase kinase 7 −0.23
MAP3K13 mitogen-activated protein kinase kinase kinase 13 1.11
MAPK10 mitogen-activated protein kinase 10 −0.87
MAPK14 mitogen-activated protein kinase 14 −0.16
MAPK15 mitogen-activated protein kinase 15 −0.39
MAST4 microtubule associated serine/threonine kinase 4 −0.82
PFKP phosphofructokinase, platelet 0.46
SCYL3 SCY1-like 3 (S. cerevisiae) −0.86
SGK3 serum/glucocorticoid regulated kinase 3 0.24
SLK STE20-like kinase (yeast) −0.36
TAOK2 TAO kinase 2 −0.87
TIE1 tyrosine kinase with immunoglobulin-and EGF-like domains −0.52
M-phase of mitotic cell cycle
ANAPC5/APC5 anaphase promoting complex subunit 5 −0.36
CDC16 cell division cycle 16 homolog (S. cerevisiae) −0.53
CDC20 cell division cycle 20 homolog (S. cerevisiae) −0.56
CDC27 cell division cycle 27 homolog (S. cerevisiae) −0.44
Nuclear hormone receptor, ligand-binding
NR1I3 nuclear receptor subfamily 1, group I, member 3 −1.28
NR2C1/TR2 nuclear receptor subfamily 2, group C, member 1 −0.75
NR2C2/TR4 nuclear receptor subfamily 2, group C, member 2 −0.65
NR2E3 nuclear receptor subfamily 2, group E, member 3 −0.65
NR3C2 nuclear receptor subfamily 3, group C, member 2 −0.47
NR4A2/NURR1 nuclear receptor subfamily 4, group A, member 2 −1.39
NR4A3/NOR1 nuclear receptor subfamily 4, group A, member 3 0.71
NR5A1 nuclear receptor subfamily 5, group A, member 1 −0.87
RARA retinoic acid receptor, alpha 0.62
Protein-tyrosine phosphatase
DCC deleted in colorectal carcinoma 0.79
PTPRD protein tyrosine phosphatase, receptor type, D −0.72
PTPRF protein tyrosine phosphatase, receptor type, F −0.64
PTPRG protein tyrosine phosphatase, receptor type, G −0.47